Companies: 10,795·Total market cap: $144.5T

Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

PTHSAMEXHealthcare● Active

$26.30

+$1.07(+4.19%)

Market Cap$17055576

P/E Ratio—

52W High$54.29

52W Low$10.6

Avg Volume15K

Open$26.30

Beta3.20

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Pelthos Therapeutics Inc.（PTHS）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PTHS · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-40.69Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$27.7MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding1.9MShares outstanding history

Next EarningsAug 12, 2026Est.Earnings history

探索 Pelthos Therapeutics Inc. 数据

分析师预测$61 · Buy

股息不分红

盈利EPS $-23.04-70.16%

财务快照

FY 2025Revenue$16.8M

202320242025

FY 2025Net Income-$43.3M▼ 444.53% YoY

202320242025

FY 2025EPS$-23.04▼ 70.16% YoY

202320242025

TTM:Revenue: $27.7MNet Income: -$51.6MEPS: $-40.69View income statement →

分析师评级与目标价

Buy3 位分析师

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$55.00Low

$26.30Current

$60.50Avg Target上涨空间 130.04%

$66.00High

合计: 3 · 买入占比: 100.0%

根据过去 3 个月内 3 位华尔街分析师，PTHS 共识评级为 Buy，12 个月平均目标价 $60.50 （较现价 $26.30 上涨空间 130.04%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Pelthos Therapeutics Inc.

$26.30+4.19%$17.1M #2

CASI Pharmaceuticals, Inc.

$0.15+3.08%$2.3M #3

$4.53+7.73%$25.4M #4

Clearside Biomedical, Inc.

$0.41+0.00%$2.1M #5

Enlivex Therapeutics Ltd.

$0.71+3.18%$17.4M #6

Kairos Pharma, Ltd.

$0.45-0.89%$9.6M

股票表现

1D+4.19%

1W+1.37%

1M+4.39%

3M+15.49%

YTD-14.13%

1Y+125.59%

5Y+125.59%

关于 Pelthos Therapeutics Inc.

CEOScott Plesha

IPO DateJul 2, 2025

Employees4

CountryUS

Websitepelthos.com

Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primar…

Biotechnology HealthcareAMEXUS

关于股票概览与关键数据

Pelthos Therapeutics Inc.（PTHS）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 2, 2025 在 AMEX 上市。截至最近交易日，PTHS 股价为 $26.30，市值约为 $17.1M。过去12个月累计回报 +125.59%，年初至今回报 -14.13%。

根据 3 位华尔街分析师，Pelthos Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $60.50。2025 财年 Pelthos Therapeutics Inc. 营收 $16.8M，净利润 -$43.3M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Pelthos Therapeutics Inc.（PTHS）股价为 $26.30，在 AMEX 上市，52周区间为 $10.60 – $54.29。

PTHS 最新股价PTHS quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议